Promoter methylation of aminopeptidase N/CD13 in malignant melanoma

Jens Wulfänger, Heike Schneider, Peter Wild, Kristian Ikenberg, Monica Rodolfo, Licia Rivoltini, Stefanie Meyer, Dagmar Riemann, Barbara Seliger

Research output: Contribution to journalArticlepeer-review


Aminopeptidase N (APN)/CD13 as ubiquitously expressed membrane peptidase exerts important functions in diverse cellular processes, such as proliferation, migration and differentiation. Previously, a role of APN in the invasiveness of melanoma cells has been demonstrated, but the underlying molecular mechanisms controlling APN expression are not understood. The present study demonstrates that lack of APN expression in primary and established melanoma cells was directly associated with a high-grade DNA methylation status of the myeloid APN promoter. Demethylation by 5-aza-2'-desoxycytidine not only induced constitutive and cytokine-regulated APN protein expression but also resulted in an increased APN-dependent migration of melanoma cells. Furthermore, its heterogeneous expression was inversely correlated to the expression of melanocytic marker proteins in established as well as in short-term cultured human melanoma cells. Staining of tissue microarrays generated from a large series of melanoma samples and control tissues demonstrated a higher APN expression in primary melanoma lesions when compared with nevi and metastases, which was neither associated with clinico-pathological parameters nor with the patients' outcome. Thus, the heterogeneous APN expression pattern in melanoma cells is epigenetically controlled and directly associated with an altered migration capacity but not of clinical significance in our study group.

Original languageEnglish
Pages (from-to)781-790
Number of pages10
Issue number4
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Promoter methylation of aminopeptidase N/CD13 in malignant melanoma'. Together they form a unique fingerprint.

Cite this